Fluad Generic Name & Formulations
Trivalent, inactivated, adjuvanted (MF59C.1) influenza vaccine (virus types A and B); contains a total of at least 45mcg of hemagglutinin per 0.5mL dose; formulation changes annually; emulsion for IM inj; may contain trace amounts of neomycin, kanamycin, hydrocortisone, egg protein, formaldehyde or CTAB; preservative-free.
Single-dose prefilled syringes (0.5mL)—10
Influenza immunization for patients ≥65yrs of age.
Fluad Dosage and Administration
<65yrs: not established. ≥65yrs: 0.5mL IM inj once in the deltoid; 1 dose per year.
Allergy to egg protein. Life-threatening reaction to any previous flu vaccine.
Fluad Boxed Warnings
Use current formulation only. Have appropriate medical treatment and supervision available. Guillain-Barré syndrome within 6 weeks of previous flu vaccine. Immunosuppressed. Syncope. May not protect all vaccine recipients against influenza disease. Pregnancy. Nursing mothers.
Concomitant with other vaccines: insufficient data (see full labeling). Immunosuppressants (eg, corticosteroids): may get suboptimal response.
Fluad Adverse Reactions
Local reactions (eg, pain, tenderness), myalgia, headache, fatigue.
Fluad Clinical Trials
Fluad Patient Counseling